Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis

Abstract excerpt

BACKGROUND: Cystic fibrosis is a common life-shortening genetic disorder in the Caucasian population (less common in other ethnic groups) caused by the mutation of a single gene that codes for the production of the cystic fibrosis transmembrane conductance regulator protein. This protein coordinates the transport of salt (and bicarbonate) across cell surfaces and the mutation most notably affects the airways. In...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Asthma and respiratory diseases
• Share to Cystic Fibrosis Research Advances
• Share to Neonatal Respiratory Health Research